Jane Street Group, LLC Point Biopharma Global Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $92,819 - $135,124	13,916 Added 95.43%	28,498 $190,000
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $546,426 - $865,042	-79,654 Reduced 84.53%	14,582 $132,000
Q1 2023 May 15, 2023	BUY	$6.78 - $8.1 $444,035 - $530,485	65,492 Added 227.85%	94,236 $685,000
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $164,415 - $281,116	28,744 New	28,744 $209,000
Q2 2022 Aug 16, 2022	SELL	$5.6 - $9.5 $265,249 - $449,977	-47,366 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$5.46 - $8.13 $258,618 - $385,085	47,366 New	47,366 $378,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.